© 2023 MJH Life Sciences™ and Cannabis Patient Care. All rights reserved.
A statement released on Thursday, January 26, 2023 from Dr. Janet Woodcock, the principal deputy commissioner of the Food and Drug Administration (FDA), announced that the FDA will work with Congress in formulating regulatory oversight to balance risk and access for products in the cannabidiol (CBD) market.
Our sister publication, Nutritional Outlook, provided thorough coverage of the FDA press release from Thursday, January 26th.
Click here to see the full article on this important update: https://www.nutritionaloutlook.com/view/fda-concludes-that-cbd-needs-its-own-regulatory-pathway-separate-from-dietary-supplements-and-food